{"id":"W4296532704","doi":"10.1016/s2152-2650(22)01552-x","title":"IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plus Lenalidomide and Rituximab Versus Placebo Plus Lenalidomide and Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Internal medicine; Follicular lymphoma; Phases of clinical research; Gastroenterology; Lymphoma; Oncology; Clinical trial; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002392385,0.002883825,0.003478224,0.0009561704,0.0006299632,0.001834622,0.002173048,0.002034893,0.007198977],"category_scores_gemma":[0.001219294,0.001210281,0.002627797,0.0006219915,0.001863685,0.001493388,0.0005732037,0.006256372,0.002045029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001681355,"about_ca_system_score_gemma":0.002154022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002219071,"about_ca_topic_score_gemma":0.006029774,"domain_scores_codex":[0.9993876,0.000278679,0.00002342637,0.00009563607,0.00005289646,0.0001616938],"domain_scores_gemma":[0.9992062,0.000128475,0.0001307186,0.00006201383,0.0000467706,0.0004258523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8977107,0.04089141,0.001080986,0.0006332739,0.001291975,0.00008732663,0.0001409068,0.0009512457,0.01350569,0.0002833282,0.002706506,0.04071663],"study_design_scores_gemma":[0.8312698,0.1623034,0.002045688,0.00003302541,0.0006444699,0.00009094308,0.00005013291,0.0005124753,0.00140948,0.0001640686,0.001445744,0.00003076094],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799707,0.005297651,0.001027684,0.001364061,0.0006118767,0.004322417,0.002328082,0.000438027,0.004639428],"genre_scores_gemma":[0.9744015,0.004305047,0.003242878,0.001689522,0.000476499,0.004997775,0.004013388,0.0001352747,0.00673821],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007198977,"threshold_uncertainty_score":0.02408302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05195107798983734,"score_gpt":0.3526723269500253,"score_spread":0.300721248960188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}